Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb:47:109-12.
doi: 10.1016/j.biocel.2013.12.006. Epub 2013 Dec 17.

α1-antitrypsin deficiency and the hepatocytes - an elegans solution to drug discovery

Affiliations
Review

α1-antitrypsin deficiency and the hepatocytes - an elegans solution to drug discovery

Linda P O'Reilly et al. Int J Biochem Cell Biol. 2014 Feb.

Abstract

Hepatocytes are metabolically active cells of the liver that play an important role in the biosynthesis of proteins including α1-antitrypsin. Mutations in the α1-antitrypsin gene can lead to protein misfolding, polymerization/aggregation and retention of protein within the endoplasmic reticulum of hepatocytes. The intracellular accumulation of α1-antitrypsin aggregates can lead to liver disease and increased likelihood of developing hepatocellular carcinomas. Of note, only ~10% of individuals with α1-antitrypsin-deficiency develop severe liver disease suggesting that there are other genetic and/or environmental factors that determine disease outcome. The nematode, Caenorhabditis elegans, is a powerful genetic model organism to study molecular aspects of human disease. In this review, we discuss the functional similarities between the intestinal cells of C. elegans and human hepatocytes and how a C. elegans model of α1-antitrypsin-deficiency can be used as a tool for identifying genetic modifiers and small molecule drugs.

Keywords: C. elegans; Hepatocyte; Liver disease; Protein aggregation; α1-Antitrypsin deficiency.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic of C. elegans intestinal cells showing the different fate of wild-type ATM and mutant ATZ proteins. Wild-type ATM travels through the ER-golgi secretory pathway and is efficiently secreted out of the cell (A). In contrast mutant ATZ protein forms polymers/aggregates within the ER and fails to be secreted (B).
Figure 2
Figure 2. High-content assay for the analysis of transgenic animals expressing the wild-type (ATM) and mutant (ATZ) forms of human α1-antitrypsin (AT) fused to GFP
(Gosai, Kwak, 2010) Brightfield (A and D) and fluorescent (B–C and E–F) images of animals expressing sGFP::ATM (upper panel) and sGFP::ATZ (lower panel). Note the accumulation of GFP-positive, protein aggregates in (F) that is lacking in (C). Bar graphs showing the average number of transgenic animals in each well (G) and the average number (H), area (I) and intensity (J) of the protein aggregates detected within the intestinal cells of animals expressing wild-type ATM (blue) and mutant ATZ (red). Figure reproduced from (Gosai, Kwak, 2010).

Similar articles

Cited by

References

    1. Branicky R, Desjardins D, Liu JL, Hekimi S. Lipid transport and signaling in Caenorhabditis elegans. Dev Dyn. 2010;239:1365–1377. - PubMed
    1. Burrows JA, Willis LK, Perlmutter DH. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci U S A. 2000;97:1796–17801. - PMC - PubMed
    1. Carlson JA, Rogers BB, Sifers RN, Finegold MJ, Clift SM, DeMayo FJ, et al. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest. 1989;83:1183–1190. - PMC - PubMed
    1. Carrell RW, Lomas DA. Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med. 2002;346:45–53. - PubMed
    1. de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest. 2002;122:1818–1829. - PubMed

Publication types